Skip to main content
Share price
  • LinkedIn
  • FR
  • EN
close icon
Accessibility
accessibility icon Accessibility
Animations
Contrast
  • Shareholders
    Shareholders
    • Institutional
      • Results center
      • Analyst Coverage
    • Individual
      • Becoming a shareholder
      • Dividend
      • Taking part in Shareholders' Meetings
  • Limited Partners
  • Individual Investors
  • Talents
Share price
Eurazeo
  • Group
    Group

    Purpose, history, strategy, governance, scope: all there is to know about Eurazeo, the leading European Private Equity player with a global reach.

    • Profile
    • Vision
    • Governance
    • Finance
    • Teams
  • Responsibility
  • Businesses
    Businesses

    Three asset classes, eight areas of expertise and the whole scope of investment strategies for companies to grow.

    • Private Equity
      • Buyout
      • Acceleration
      • Venture
      • Private Funds Group
    • Private Debt
      • Direct Lending
      • Asset-based Finance
    • Real Assets
      • Real Estate
      • Infrastructure
  • Investments
  • Newsroom
    Newsroom

    All our press releases and press kits for journalists and the media: the essentials of Eurazeo news.

    • Highlights
    • Press Releases
    • Publications
    • Tribunes
    • Regulated Information
    • Medias
    • Policies
icon
Portfolio

Updated 24/05/2022

M2I Life Sciences

Share on

M2I Life Sciences designs and reproduces in the laboratory molecules to fight against insects
Growth
Status
In portfolio
Date d’investissement
06/2017
Sector
LifeSciences
Location
France
www.m2i-lifesciences.com

Stay connected

  • LinkedIn
  • Download Wechat application

TOP OF THE PAGE
Eurazeo
  • Contacts
  • Talents
  • Terms and conditions of use
  • Sitemap
  • Personal Data Protection Policy
  • Regulated Affiliates
  • Cookies management
Subscribe to our newsletter

Copyright Eurazeo © 2021. All rights reserved.